Education
About Us
Working with TipRanks
Follow Us
XORTX Therapeutics Inc (XRTX)
NASDAQ:XRTX
Total Valuation
XORTX Therapeutics Inc has a market cap or net worth of C$3.57M. The enterprise value is $3.28M.
Market CapC$3.57M
Enterprise Value$3.28M
Share Statistics
XORTX Therapeutics Inc has 5,784,688 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,784,688
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
XORTX Therapeutics Inc’s return on equity (ROE) is -0.95 and return on invested capital (ROIC) is -116.22%.
Return on Equity (ROE)-0.95
Return on Assets (ROA)-0.77
Return on Invested Capital (ROIC)-116.22%
Return on Capital Employed (ROCE)-1.18
Revenue Per Employee0.00
Profits Per Employee-2.27M
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of XORTX Therapeutics Inc is ―. XORTX Therapeutics Inc’s PEG ratio is -0.11.
PE Ratio―
PS Ratio0.00
PB Ratio1.01
Price to Fair Value1.01
Price to FCF-0.97
Price to Operating Cash Flow-0.77
PEG Ratio-0.11
Income Statement
In the last 12 months, XORTX Therapeutics Inc had revenue of 0.00 and earned -4.54M in profits. Earnings per share was -1.58.
Revenue0.00
Gross Profit-160.66K
Operating Income-5.64M
Pretax Income-4.54M
Net Income-4.54M
EBITDA-4.38M
Earnings Per Share (EPS)-1.58
Cash Flow
In the last 12 months, operating cash flow was -2.94M and capital expenditures -29.25K, giving a free cash flow of -2.97M billion.
Operating Cash Flow-2.94M
Free Cash Flow-2.97M
Free Cash Flow per Share-0.51
Dividends & Yields
XORTX Therapeutics Inc pays an annual dividend of $0.075, resulting in a dividend yield of ―
Dividend Per Share$0.075
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.47
52-Week Price Change-49.59%
50-Day Moving Average0.68
200-Day Moving Average0.85
Relative Strength Index (RSI)46.75
Average Volume (3m)3.79M
Important Dates
XORTX Therapeutics Inc upcoming earnings date is Mar 26, 2026, TBA (Confirmed).
Last Earnings DateNov 15, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend DateJan 31, 2014
Financial Position
XORTX Therapeutics Inc as a current ratio of 3.53, with Debt / Equity ratio of 3.96%
Current Ratio3.53
Quick Ratio3.53
Debt to Market Cap0.01
Net Debt to EBITDA0.80
Interest Coverage Ratio0.00
Taxes
In the past 12 months, XORTX Therapeutics Inc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
XORTX Therapeutics Inc EV to EBITDA ratio is -0.31, with an EV/FCF ratio of -0.27.
EV to Sales0.00
EV to EBITDA-0.31
EV to Free Cash Flow-0.27
EV to Operating Cash Flow-0.27
Balance Sheet
XORTX Therapeutics Inc has C$0.00 in cash and marketable securities with C$82.23K in debt, giving a net cash position of -C$82.23K billion.
Cash & Marketable SecuritiesC$0.00
Total DebtC$82.23K
Net Cash-C$82.23K
Net Cash Per Share-C$0.01
Tangible Book Value Per ShareC$1.58
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for XORTX Therapeutics Inc is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target―
Price Target Upside―
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―